Key roles of endothelin-1 and p38 MAPK in the regulation of atrial stretch response

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 300, Issue 1, 2011, Pages

  Kerkelä, Risto ^a   Ilves, Mika ^a   Pikkarainen, Sampsa ^a   Tokola, Heikki ^a   Ronkainen, Veli Pekka ^a   Majalahti, Theresa ^a   Leppäluoto, Juhani ^a   Vuolteenaho, Olli ^a   Ruskoaho, Heikki ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

ANG II; Atrial contractility; Cardiac hypertrophy; GATA 4; Natriuretic peptides

Indexed keywords

ADRENOMEDULLIN; APELIN; ATRIAL NATRIURETIC FACTOR; BOSENTAN; BRAIN NATRIURETIC PEPTIDE; CANDESARTAN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MYOSIN HEAVY CHAIN BETA; PROTEIN C FOS; TRANSCRIPTION FACTOR ELK 1; TRANSCRIPTION FACTOR GATA 4;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; ENZYME INHIBITION; HEART ATRIUM; HEART ATRIUM CONTRACTILITY; HEART ATRIUM HYPERTROPHY; HEART CONTRACTION; MALE; MUSCLE STRETCHING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; RAT;

ANIMALS; ATRIAL FUNCTION; ENDOTHELIN-1; GATA4 TRANSCRIPTION FACTOR; MALE; MODELS, ANIMAL; MYOCARDIAL CONTRACTION; MYOSIN HEAVY CHAINS; NATRIURETIC PEPTIDE, BRAIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ENDOTHELIN; REFLEX, STRETCH;

EID: 78650664278     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00853.2009     Document Type: Article

References (50)

1. Aoyagi T, Izumo S. Mapping of the pressure response element of the c-fos gene by direct DNA injection into beating hearts. J Biol Chem 268: 27176-27179, 1993.
2. Bisping E, Tenderich G, Barckhausen P, Stumme B, Bruns S, von Lewinski D, Pieske B. Atrial myocardium is the predominant inotropic target of adrenomedullin in the human heart. Am J Physiol Heart Circ Physiol 293: H3001-H3007, 2007.
3. Bohm F, Pernow J. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc Res 76: 8-18, 2007.
4. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
5. Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol 26: 809-820, 1994.
6. Brundel BJ, Van Gelder IC, Tuinenburg AE, Wietses M, Van Veldhuisen DJ, Van Gilst WH, Crijns HJ, Henning RH. Endothelin system in human persistent and paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 12: 737-742, 2001.
7. Burstein B, Libby E, Calderone A, Nattel S. Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences. Circulation 117: 1630-1641, 2008.
8. Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 51: 802-809, 2008.
9. Channick RN, Simonneau G, Sitbon O, Robbins IM, Frost A, Tapson VF, Badesch DB, Roux S, Rainisio M, Bodin F, Rubin LJ. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. Lancet 358: 1119-1123, 2001. (Pubitemid 32971843)
10. Charron F, Tsimiklis G, Arcand M, Robitaille L, Liang Q, Molkentin JD, Meloche S, Nemer M. Tissue-specific GATA factors are transcrip- tional effectors of the small GTPase RhoA. Genes Dev 15: 2702-2719, 2001.
11. Giannessi D, Del Ry S, Vitale RL. The role of endothelins and their receptors in heart failure. Pharmacol Res 43: 111-126, 2001.
12. Glenn DJ, Rahmutula D, Nishimoto M, Liang F, Gardner DG. Atrial natriuretic peptide suppresses endothelin gene expression and proliferation in cardiac fibroblasts through a GATA4-dependent mechanism. Cardiovasc Res 84: 209-217, 2009.
13. Goette A, Bukowska A, Lendeckel U. Non-ion channel blockers as anti-arrhythmic drugs (reversal of structural remodeling). Curr Opin Pharmacol 7: 219-224, 2007.
14. Gupta M, Zak R, Libermann TA, Gupta MP. Tissue-restricted expression of the cardiacα-myosin heavy chain gene is controlled by a downstream repressor element containing a palindrome of two ets-binding sites. Mol Cell Biol 18: 7243-7258, 1998.
15. Hautala N, Tenhunen O, Szokodi I, Ruskoaho H. Direct left ventricular wall stretch activates GATA4 binding in perfused rat heart: involvement of autocrine/paracrine pathways. Pflügers Arch 443: 362-369, 2002.
16. Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7: 589-600, 2006.
17. Hipskind RA, Rao VN, Mueller CG, Reddy ES, Nordheim A. Etsrelated protein Elk-1 is homologous to the c-fos regulatory factor p62TCF. Nature 354: 531-534, 1991.
18. Holubarsch C, Hasenfuss G, Schmidt-Schweda S, Knorr A, Pieske B, Ruf T, Fasol R, Just H. Angiotensin I and II exert inotropic effects in atrial but not in ventricular human myocardium. An in vitro study under physiological experimental conditions. Circulation 88: 1228-1237, 1993.
19. Ishikawa T, Li LM, Shinmi O, Kimura S, Yanagisawa M, Goto K, Masaki T. Characteristics of binding of endothelin-1 and endothelin-3 to rat hearts. Developmental changes in mechanical responses and receptor subtypes. Circ Res 69: 918-926, 1991.
20. Ito H, Hirata Y, Adachi S, Tanaka M, Tsujino M, Koike A, Nogami A, Murumo F, Hiroe M. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest 92: 398-403, 1993.
21. Kedzierski RM, Yanagisawa M. Endothelin system: the double-edged sword in health and disease. Annu Rev Pharmacol Toxicol 41: 851-876, 2001.
22. Kerkela R, Force T. p38 mitogen-activated protein kinase: a future target for heart failure therapy? J Am Coll Cardiol 48: 556-558, 2006.
23. Kerkelä R, Pikkarainen S, Majalahti-Palviainen T, Tokola H, Ruskoaho H. Distinct roles of mitogen-activated protein kinase pathways in GATA-4 transcription factor-mediated regulation of B-type natriuretic peptide gene. J Biol Chem 277: 13752-13760, 2002.
24. Kirkby NS, Hadoke PWF, Bagnall AJ, Webb DJ. The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house? Br J Pharmacol 153: 1105-1119, 2007.
25. Laine M, Weckstrom M, Vuolteenaho O, Arjamaa O. Effect of ryanodine on atrial natriuretic peptide secretion by contracting and quiescent rat atrium. Pflügers Arch 426: 276-283, 1994. (Pubitemid 24091088)
26. Liang Q, Wiese RJ, Bueno OF, Dai YS, Markham BE, Molkentin JD. The transcription factor GATA4 is activated by extracellular signalregulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes. Mol Cell Biol 21: 7460-7469, 2001.
27. Liao P, Georgakopoulos D, Kovacs A, Zheng M, Lerner D, Pu H, Saffitz J, Chien K, Xiao RP, Kass DA, Wang Y. The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy. Proc Natl Acad Sci USA 98: 12283-12288, 2001.
28. Liao P, Wang SQ, Wang S, Zheng M, Zheng M, Zhang SJ, Cheng H, Wang Y, Xiao RP. p38 Mitogen-activated protein kinase mediates a negative inotropic effect in cardiac myocytes. Circ Res 90: 190-196, 2002.
29. Magga J, Vuolteenaho O, Marttila M, Ruskoaho H. Endothelin-1 is involved in stretch-induced early activation of B-type natriuretic peptide gene expression in atrial but not in ventricular myocytes: acute effects of mixed ETA/ETB and AT1 receptor antagonists in vivo and in vitro. Circulation 96: 3053-3062, 1997.
30. Majalahti-Palviainen T, Hirvinen M, Tervonen V, Ilves M, Ruskoaho H, Vuolteenaho O. Gene structure of a new cardiac peptide hormone: a model for heart-specific gene expression. Endocrinology 141: 731-740, 2000.
31. Mayyas F, Niebauer M, Zurick A, Barnard J, Gillinov AM, Chung MK, Van Wagoner DR. Association of left atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with structural heart disease. Circ Arrhythm Electrophysiol 3: 369-379, 2010.
32. Molenaar P, O'Reilly G, Sharkey A, Kuc RE, Harding DP, Plumpton C, Gresham GA, Davenport AP. Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res 72: 526-538, 1993.
33. Molkentin JD, Dorn GW II. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 63: 391-426, 2001.
34. Morawietz H, Szibor M, Goettsch W, Bartling B, Barton M, Shaw S, Koerfer R, Zerkowski HR, Holtz J. Deloading of the left ventricle by ventricular assist device normalizes increased expression of endothelin ETA receptors but not endothelin-converting enzyme-1 in patients with end-stage heart failure. Circulation 102: III188-III193, 2000.
35. Pieske B, Beyermann B, Breu V, Loffler BM, Schlotthauer K, Maier LS, Schmidt-Schweda S, Just H, Hasenfuss G. Functional effects of endothelin and regulation of endothelin receptors in isolated human nonfailing and failing myocardium. Circulation 99: 1802-1809, 1999.
36. Pikkarainen S, Kerkelä R, Pöntinen J, Majalahti-Palviainen T, Tokola H, Eskelinen S, Vuolteenaho O, Rukoaho H. Decoy oligonucleotide characterization of GATA-4 transcription factor in hypertrophic agonist induced responses of cardiac myocytes. J Mol Med 80: 51-60, 2002.
37. Pikkarainen S, Tokola H, Kerkela R, Majalahti-Palviainen T, Vuolteenaho O, Ruskoaho H. Endothelin-1-specific activation of B-type natriuretic peptide gene via p38 mitogen-activated protein kinase and nuclear ETS Factors. J Biol Chem 278: 3969-3975, 2003.
38. Purcell NH, Darwis D, Bueno OF, Muller JM, Schule R, Molkentin JD. Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes. Mol Cell Biol 24: 1081-1095, 2004.
39. Sadoshima J, Izumo S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol 59: 551-571, 1997.
40. Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM. Renin-angiotensin system and cardiovascular risk. Lancet 369: 1208-1219, 2007.
41. Schreiber E, Matthias P, Muller MM, Schaffner W. Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res 17: 6419, 1989. (Pubitemid 19198635)
42. Sprenkle AB, Murray SF, Glembotski CC. Involvement of multiple cis elements in basal- and β-adrenergic agonist-inducible atrial natriuretic factor transcription. Roles for serum response elements and an SP-1-like element. Circ Res 77: 1060-1069, 1995.
43. Sugden PH. An overview of endothelin signaling in the cardiac myocyte. J Mol Cell Cardiol 35: 871-886, 2003.
44. Szokodi I, Kerkela R, Kubin AM, Sarman B, Pikkarainen S, Konyi A, Horvath IG, Papp L, Toth M, Skoumal R, Ruskoaho H. Functionally opposing roles of extracellular signal-regulated kinase 1/2 and p38 mitogen- activated protein kinase in the regulation of cardiac contractility. Circulation 118: 1651-1658, 2008.
45. Szokodi I, Kinnunen P, Tavi P, Weckstrom M, Toth M, Ruskoaho H. Evidence for cAMP-independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide. Circulation 97: 1062-1070, 1998.
46. Szokodi I, Tavi P, Foldes G, Voutilainen-Myllyla S, Ilves M, Tokola H, Pikkarainen S, Piuhola J, Rysa J, Toth M, Ruskoaho H. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res 91: 434-440, 2002.
47. Thibault G, Doubell AF, Garcia R, Lariviere R, Schiffrin EL. Endothelin- stimulated secretion of natriuretic peptides by rat atrial myocytes is mediated by endothelin A receptors. Circ Res 74: 460-470, 1994.
48. Vuolteenaho O, Koistinen P, Martikkala V, Takala T, Leppaluoto J. Effect of physical exercise in hypobaric conditions on atrial natriuretic peptide secretion. Am J Physiol Regul Integr Comp Physiol 263: R647-R652, 1992.
49. Xiao HD, Fuchs S, Campbell DJ, Lewis W, Dudley SC Jr, Kasi VS, Hoit BD, Keshelava G, Zhao H, Capecchi MR, Bernstein KE. Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death. Am J Pathol 165: 1019-1032, 2004.
50. Yanagisawa M, Masaki T. Endothelin, a novel endothelium-derived peptide. Pharmacological activities, regulation and possible roles in cardiovascular control. Biochem Pharmacol 38: 1877-1883, 1989